IE
KMTS

Israel Englander’s Kestra Medical Technologies KMTS Stock Holding History

Israel Englander’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.16M Sell
163,387
-34,104
-17% -$714K ﹤0.01% 3169
2026
Q1 		$3.94M Sell
197,491
-19,647
-9% -$463K ﹤0.01% 3211
2025
Q4 		$5.76M Sell
217,138
-2,568
-1% -$66.1K ﹤0.01% 2858
2025
Q3 		$5.22M Buy
219,706
+185,090
+535% +$3.31M ﹤0.01% 3106
2025
Q2 		$574K Sell
34,616
-408,255
-92% -$8.91M ﹤0.01% 4813
2025
Q1 		$11M Buy
+442,871
New +$10.2M 0.01% 2077

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Israel Englander's KMTS Position: Q2 2026 in Review

Israel Englander reduced its Kestra Medical Technologies (KMTS) stake by 17% in Q2 2026, selling an estimated $714K and leaving 163,387 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3169.

Israel Englander first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $11M in Q1 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Israel Englander held 163,387 shares of Kestra Medical Technologies worth $4.16M as of Q2 2026.
  • Israel Englander sold 34,104 Kestra Medical Technologies shares in Q2 2026, an estimated $714K.
  • Kestra Medical Technologies made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3169 holding.
  • Israel Englander first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • Israel Englander's Kestra Medical Technologies position peaked at $11M in Q1 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.